Thursz, Mark R.

Publishing since 1995 (Senior)

Has published 26 publications in 16 years

Number of publications published per year by Thursz, Mark R.. (Source : PubMed)

Distribution of publications types for Thursz, Mark R.. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Khamri W, Walker MM, Clark P, Atherton JC, Thursz MR, Bamford KB, Lechler RI, Lombardi G. Helicobacter pylori stimulates dendritic cells to induce interleukin-17 expression from CD4+ T lymphocytes.  Infect. Immun.  2010;78;2  
•  Cooke GS, Main J, Thursz MR. Treatment for hepatitis B.  BMJ  2010;340  
•  Cobbold JF, Anstee QM, Goldin RD, Williams HR, Matthews HC, North BV, Absalom N, Thomas HC, Thursz MR, Cox RD, Taylor-Robinson SD, Cox IJ. Phenotyping murine models of non-alcoholic fatty liver disease through metabolic profiling of intact liver tissue.  Clinical science (London, England : 1979)  2009;116;5  
•  Anstee QM, Wright M, Goldin R, Thursz MR. Parenchymal extinction: coagulation and hepatic fibrogenesis.  Clin Liver Dis  2009;13;1  
•  Grant AM, Wileman SM, Ramsay CR, Mowat NA, Krukowski ZH, Heading RC, Thursz MR, Campbell MK. Minimal access surgery compared with medical management for chronic gastro-oesophageal reflux disease: UK collaborative randomised trial.  BMJ  2008;337  
•  Anderson AE, Worku ML, Khamri W, Bamford KB, Walker MM, Thursz MR. TLR9 polymorphisms determine murine lymphocyte responses to Helicobacter: results from a genome-wide scan.  Eur. J. Immunol.  2007;37;6  
•  Frodsham AJ, Zhang L, Dumpis U, Taib NA, Best S, Durham A, Hennig BJ, Hellier S, Knapp S, Wright M, Chiaramonte M, Bell JI, Graves M, Whittle HC, Thomas HC, Thursz MR, Hill AV. Class II cytokine receptor gene cluster is a major locus for hepatitis B persistence.  Proc. Natl. Acad. Sci. U.S.A.  2006;103;24  
•  Rashid ST, Thursz MR, Razvi NA, Voller R, Orchard T, Rashid ST, Shlebak AA. Venous thromboprophylaxis in UK medical inpatients.  J R Soc Med  2005;98;11  
•  Khamri W, Moran AP, Worku ML, Karim QN, Walker MM, Annuk H, Ferris JA, Appelmelk BJ, Eggleton P, Reid KB, Thursz MR. Variations in Helicobacter pylori lipopolysaccharide to evade the innate immune component surfactant protein D.  Infect. Immun.  2005;73;11  
•  Moran AP, Khamri W, Walker MM, Thursz MR. Role of surfactant protein D (SP-D) in innate immunity in the gastric mucosa: evidence of interaction with Helicobacter pylori lipopolysaccharide.  J. Endotoxin Res.  2005;11;6  

[ See timeline ] [ See all publications ]